Back to Search
ZHENGHUA LIU, L.AC., O.M.D.
L.AC., O.M.D.
Acupuncturist
NPI: 1306986336Individual
Specialties, Licenses & Credentials
Clinical Trials (1)
1
Linked Trials
1
Recruiting
0
With Results
Research & Publications (20)
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
PMID 28237263·Lancet·2017
4-observational
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
PMID 27295427·N Engl J Med·2016
4-observational
Postexercise improvement in insulin-stimulated glucose uptake occurs concomitant with greater AS160 phosphorylation in muscle from normal and insulin-resistant rats.
PMID 24608437·Diabetes·2014
7-preclinical
Exercise-induced capillary growth in human skeletal muscle and the dynamics of VEGF.
PMID 24450403·Microcirculation·2014
6-review
GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways.
PMID 23684008·Metabolism·2013
8-other
Exercise training and cardiometabolic diseases: focus on the vascular system.
PMID 23519745·Curr Hypertens Rep·2013
6-review
The vascular endothelium in diabetes and its potential as a therapeutic target.
PMID 23397463·Rev Endocr Metab Disord·2013
6-review
Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance.
PMID 23002035·Diabetes·2013
7-preclinical
Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans.
PMID 21617098·Diabetes Care·2011
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20432 SILVERADO AVE, SUITE #1
CUPERTINO, CA 95014 - Phone
- (408) 252-7200
Quick Facts
- NPI
- 1306986336
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile